VITR — Vitrolife AB Cashflow Statement
0.000.00%
- SEK20.31bn
- SEK21.21bn
- SEK3.61bn
Annual cashflow statement for Vitrolife AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 366 | 460 | 537 | -3,712 | 674 |
Depreciation | |||||
Non-Cash Items | 7.71 | -30.8 | 80 | 4,376 | 67 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -102 | -154 | -377 | -332 | -276 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 356 | 384 | 636 | 757 | 907 |
Capital Expenditures | -20.1 | -62.4 | -87 | -119 | -202 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.132 | -6,456 | -57 | -5 | -175 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -20.2 | -6,518 | -144 | -124 | -377 |
Financing Cash Flow Items | -10.8 | -33 | 7 | -1 | -1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -26.6 | 5,749 | -582 | -300 | -286 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 284 | -343 | -51 | 283 | 273 |